MSLP - MusclePharm Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 516.57M
Enterprise Value 337.09M
Trailing P/E N/A
Forward P/E 1-3.33
PEG Ratio (5 yr expected) 1-0.09
Price/Sales (ttm)0.16
Price/Book (mrq)N/A
Enterprise Value/Revenue 30.36
Enterprise Value/EBITDA 6-16.80

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018

Profitability

Profit Margin -7.77%
Operating Margin (ttm)-3.32%

Management Effectiveness

Return on Assets (ttm)-7.14%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)103.61M
Revenue Per Share (ttm)7.24
Quarterly Revenue Growth (yoy)3.50%
Gross Profit (ttm)32.15M
EBITDA -2.21M
Net Income Avi to Common (ttm)-8.05M
Diluted EPS (ttm)-0.56
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.44M
Total Cash Per Share (mrq)0.16
Total Debt (mrq)22.06M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.00
Book Value Per Share (mrq)-1.04

Cash Flow Statement

Operating Cash Flow (ttm)-3.35M
Levered Free Cash Flow (ttm)836.62k

Trading Information

Stock Price History

Beta 4.59
52-Week Change 3-33.53%
S&P500 52-Week Change 316.14%
52 Week High 31.70
52 Week Low 30.00
50-Day Moving Average 31.12
200-Day Moving Average 30.91

Share Statistics

Avg Vol (3 month) 313.16k
Avg Vol (10 day) 32.24k
Shares Outstanding 515.06M
Float 7.79M
% Held by Insiders 165.78%
% Held by Institutions 110.98%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/850
Last Split Date 3Nov 26, 2012